IntroductionPharmacogenomics is a cornerstone of precision medicine. Its major aim is to tailor drug therapy based on individual genetic variations which influence drug pharmacokinetics and dynamics. In the field of oncology, pharmacogenomic testing has become an efficient tool for predicting treatment outcomes and avoiding severe adverse reactions. Understanding the perspectives, attitudes, and willingness of cancer patients toward pharmacogenomic testing is critical for successful implementati